Citation Impact
Citing Papers
The validation of a diagnostic rule for gout without joint fluid analysis: a prospective study
2014
Contemporary epidemiology of gout in the UK general population
2011
Comorbidities in patients with gout prior to and following diagnosis: case-control study
2014
Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey
2012
Cognitive and emotional influences in anterior cingulate cortex
2000 Standout
Pilot study of a multidisciplinary gout patient education and monitoring program
2016
Familial aggregation of gout and relative genetic and environmental contributions: a nationwide population study in Taiwan
2013
Adrenergic α2C-Receptors Modulate the Acoustic Startle Reflex, Prepulse Inhibition, and Aggression in Mice
1998 StandoutNobel
Investigations of Temperament at Three to Seven Years: The Children's Behavior Questionnaire
2001 Standout
Evidence for opiate-dopamine cross-sensitization in nucleus accumbens: Studies of conditioned reward
1992
The effects of d -amphetamine, chlordiazepoxide, α-flupenthixol and behavioural manipulations on choice of signalled and unsignalled delayed reinforcement in rats
2000
The neural basis of drug craving: An incentive-sensitization theory of addiction
1993 Standout
Association of TLR4 Gene rs2149356 Polymorphism with Primary Gouty Arthritis in a Case-Control Study
2013
DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task
2000 StandoutNobel
An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population
2015
The ascending neuromodulatory systems in learning by reinforcement: comparing computational conjectures with experimental findings
1995
Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study
2012
Psychopharmacology of conditioned reward: evidence for a rewarding signal at D 1 -like dopamine receptors
1999
The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012
2016
Revisiting comorbidities in gout: a cluster analysis
2013
Impact of diabetes against the future risk of developing gout
2010
Getting Formal with Dopamine and Reward
2002 Standout
Effects of beta-adrenoceptor blockade on components of human decision-making
2004
A meta-analysis of 25 years of mood-creativity research: Hedonic tone, activation, or regulatory focus?
2008 Standout
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
2005 Standout
Association of Common Polymorphisms in GLUT9 Gene with Gout but Not with Coronary Artery Disease in a Large Case-Control Study
2008
Gout: why is this curable disease so seldom cured?
2012
Dissociable effects of anterior and posterior cingulate cortex lesions on the acquisition of a conditional visual discrimination: Facilitation of early learning vs. impairment of late learning
1996
Seasonality and trends in the incidence and prevalence of gout in England and Wales 1994–2007
2008
Pharmacological Manipulations of the ??2-Noradrenergic System
1994
Prevalence of gout with comorbidity aggregations in southern Taiwan
2014
Impulsivity, Compulsivity, and Top-Down Cognitive Control
2011 Standout
Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective
2005 Standout
Noradrenaline- and time-dependent changes in neocortical α2- and β1-adrenoceptor binding in dorsal noradrenergic bundle-lesioned rats
1987
Health-related quality of life in gout: a systematic review
2013
Neurobiology of the structure of personality: Dopamine, facilitation of incentive motivation, and extraversion
1999
Alpha2C-adrenoceptor overexpression disrupts execution of spatial and non-spatial search patterns
1999 StandoutNobel
Contributions of the Amygdala to Emotion Processing: From Animal Models to Human Behavior
2005 Standout
Effectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot study
2014
Incidence and prevalence of gout in Western Sweden
2016
The Neural Basis of Addiction: A Pathology of Motivation and Choice
2005 Standout
Associative Processes in Addiction and Reward The Role of Amygdala‐Ventral Striatal Subsystems
1999
Gout
2009 Standout
Functional Imaging of Neural Responses to Expectancy and Experience of Monetary Gains and Losses
2001 StandoutNobel
Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study
2014
Addiction Motivation Reformulated: An Affective Processing Model of Negative Reinforcement.
2004 Standout
Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol
2016
The role of dopamine in drug abuse viewed from the perspective of its role in motivation
1995
The Reorienting System of the Human Brain: From Environment to Theory of Mind
2008 Standout
Effects of dopamine depletion from the caudate-putamen and nucleus accumbens septi on the acquisition and performance of a conditional discrimination task
1990
Symmetrical effects of amphetamine and alpha-flupenthixol on conditioned punishment and conditioned reinforcement: contrasts with midazolam
1997
The biological, social and clinical bases of drug addiction: commentary and debate
1996
Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens
1991
Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008
2012
Dopamine functions in appetitive and defensive behaviours
1992
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Damage to ceruleo-cortical noradrenergic projections impairs locally cued but enhances spatially cued water maze acquisition
1990
From mice to men: What can we learn about personality from animal research?
2001 Standout
A neuropsychological theory of positive affect and its influence on cognition.
1999 Standout
Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study
2012
Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
2000 Nature
Comparative effects of excitotoxic lesions of the hippocampus and septum/diagonal band on conditional visual discrimination and spatial learning
1993
Gout
2016 Standout
The prevalence of rheumatic diseases in central Greece: a population survey
2010
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Limbic-striatal interactions in reward-related processes
1989
α2C-Adrenoceptor-Overexpressing Mice Are Impaired in Executing Nonspatial and Spatial Escape Strategies
1998 StandoutNobel
The neural basis of human error processing: Reinforcement learning, dopamine, and the error-related negativity.
2002 Standout
Neurobiology of Depression
2002 Standout
The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort
2014
Dopamine and conditioned reinforcement
1991
The reserpine-sensitive dopamine pool mediates (+)-amphetamine-conditioned reward in the place preference paradigm
1990
Behavioral responses to psychomotor stimulant drugs: Localization in the central nervous system
1988
Dopamine and the mechanisms of cognition: Part II. D-amphetamine effects in human subjects performing a selective attention task
1998
Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout
2007
Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial
2018
Risk factors for gout and prevention: a systematic review of the literature
2011
Systematic review of the prevalence of gout and hyperuricaemia in Australia
2012
Dopamine and conditioned reinforcement
1991
The role of the basal ganglia in habit formation
2006 Standout
Determinants of the prevalence of gout in the general population: a systematic review and meta-regression
2014
Rilonacept (interleukin‐1 trap) for prevention of gout flares during initiation of uric acid–lowering therapy: Results from a phase III randomized, double‐blind, placebo‐controlled, confirmatory efficacy study
2012
The role of impulsive behavior in drug abuse
2008
Conflict monitoring and cognitive control.
2001 Standout
Neural systems implicated in delayed and probabilistic reinforcement
2006
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
2010 Standout
Frequency and risk factors of gout flares in a large population-based cohort of incident gout
2011
Activation of Monkey Locus Coeruleus Neurons Varies With Difficulty and Performance in a Target Detection Task
2004
Neurocircuitry of Addiction
2009 Standout
Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort
2015
Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012
2013
Enhanced responding for conditioned reward produced by intra-accumbens amphetamine is potentiated after cocaine sensitization
1999
Dopamine, learning and motivation
2004 Standout
Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232
1992 StandoutNobel
Second-order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking behaviour
2000
Global epidemiology of gout: prevalence, incidence and risk factors
2015 Standout
Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens
1984
A Neural Substrate of Prediction and Reward
1997 StandoutScience
Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task
1994
The role of noradrenaline in tuning and dopamine in switching between signals in the CNS
1985
Abnormal neural oscillations and synchrony in schizophrenia
2010 Standout
Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study
2012
Behavioral functions of locus coeruleus derived from cellular attributes
1985
Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress
2006 StandoutScience
Use of Diuretics and Risk of Incident Gout: A Population‐Based Case–Control Study
2013
Norepinephrine induces pathway-specific long-lasting potentiation and depression in the hippocampal dentate gyrus.
1989
Role of central noradrenaline neurons in the contextual control of latent inhibition in taste aversion learning
1986
Predictive Reward Signal of Dopamine Neurons
1998 Standout
The abolition of the partial reinforcement extinction effect (PREE) by amphetamine
1985
Mutation of the α2A-Adrenoceptor Impairs Working Memory Performance and Annuls Cognitive Enhancement by Guanfacine
2002 StandoutNobel
Enhancement of Locomotor Activity and Conditioned Reward to Cocaine by Brain-Derived Neurotrophic Factor
1999
Gout
2021 Standout
Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal
1983
Cortical noradrenaline, attention and arousal
1984
A faulty negative feedback control underlies the schizophrenic syndrome?
1991 StandoutNobel
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
The role of dopamine in locomotor activity and learning
1983
NEUROBIOLOGICAL CONSTRAINTS ON BEHAVIORAL MODELS OF MOTIVATION
1997
The abolition of the partial reinforcement extinction effect (PREE) by amphetamine: Disruption of control by nonreinforcement
1987
AN INTEGRATIVE THEORY OF LOCUS COERULEUS-NOREPINEPHRINE FUNCTION: Adaptive Gain and Optimal Performance
2005 Standout
Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis
2013
Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
1986 Standout
Catecholamines and conditioned blocking: effects of ventral tegmental, septal and frontal 6-hydroxydopamine lesions in rats
1987
Dopamine Receptors: From Structure to Function
1998 Standout
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
2006 Standout
Behavioural tolerance to amphetamine and other psychostimulants: The case for considering behavioural mechanisms
1983
Impaired hippocampal plasticity in mice lacking the Cbeta1 catalytic subunit of cAMP-dependent protein kinase.
1996 StandoutNobel
6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine
1986
The Prevalence and Features of Korean Gout Patients Using the National Health Insurance Corporation Database
2011
The Neural Basis of Error Detection: Conflict Monitoring and the Error-Related Negativity.
2004 Standout
The neuropsychology of schizophrenia
1991
Works of M. Gaskin being referenced
Contrasting interactions of pipradrol, d-amphetamine, cocaine, cocaine analogues, apomorphine and other drugs with conditioned reinforcement
1983
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005
2007
The effects of lesions to ascending noradrenergic neurons on discrimination learning and performance in the rat
1983
Gout in the UK and Germany: prevalence, comorbidities and management in general practice
2008